Thermo Fisher Scientific

Equities

TMO

US8835561023

Advanced Medical Equipment & Technology

Market Closed - Nyse 04:00:01 2024-02-23 pm EST 5-day change 1st Jan Change
564.7 USD +0.75% Intraday chart for Thermo Fisher Scientific +3.08% +6.39%
This article is reserved for members
To unlock the article, REGISTER!
Already a customer? Log In
LBT Innovations Delivers APAS Hardware, Software to Thermo Fisher MT
Thermo Fisher Scientific Raises Quarterly Dividend 11% to 39 Cents Per Share DJ
Thermo Fisher Scientific Increases Quarterly Dividend 11% to $0.39 Per Share, Payable April 15 to Shareholders of Record March 15 MT
Thermo Fisher Scientific Inc. Increases Quarterly Cash Dividend, Payable on April 15, 2024 CI
Thermo Fisher Scientific Inc. Launches New Ion Chromatography Instrument to Improve Reliability, Efficiency, and Functional Adaptability for Labs CI
IQVIA quarterly results beat estimates on strong demand for research services RE
Thermo Fisher Scientific Expands GMP Laboratory Service Offerings with Biosafety Testing Including Mycoplasma Testing CI
Thermo Fisher Scientific Insider Sold Shares Worth $5,556,287, According to a Recent SEC Filing MT
Thermo Fisher Scientific Insider Sold Shares Worth $8,186,092, According to a Recent SEC Filing MT
Switzerland’s Xlife Sciences, Abu Dhabi Expand Existing Life Sciences Partnership MT
Global markets live: Meta, Amazon, Apple, Tesla, Intel... Our Logo
Job data is good for the economy, not for rate cuts Our Logo
UK Competition Watchdog to Probe Thermo Fisher Scientific's Potential Acquisition of Olink MT
UBS Adjusts Thermo Fisher Scientific's Price Target to $650 From $640, Maintains Buy Rating MT
Raymond James Adjusts Thermo Fisher Scientific's Price Target to $605 From $515, Keeps Outperform Rating MT
Deutsche Bank Raises Thermo Fisher Scientific Price Target to $600 From $565, Maintains Buy Rating MT
Did you expect anything different? Our Logo
Stifel Raises Price Target on Thermo Fisher Scientific to $595 From $530, Maintains Buy Rating MT
Goldman Sachs Raises Price Target on Thermo Fisher Scientific to $550 From $520, Maintains Buy Rating MT
Evercore ISI Raises Price Target on Thermo Fisher Scientific to $575 From $560, Keeps Outperform Rating MT
Jefferies Raises Price Target on Thermo Fisher Scientific to $540 From $435, Keeps Hold Rating MT
Barclays Raises Price Target on Thermo Fisher Scientific to $590 From $555, Keeps Equalweight Rating MT
Baird Cuts Price Target on Thermo Fisher Scientific to $597 From $609, Keeps Outperform Rating MT
TD Cowen Boosts Price Target on Thermo Fisher Scientific to $612 From $590, Keeps Outperform Rating MT
RBC Raises Price Target on Thermo Fisher Scientific to $642 From $592, Says Guidance Sets Stage for 'Beat/Raise Strategy' in 2024; Outperform Kept MT
Chart Thermo Fisher Scientific
More charts
Thermo Fisher Scientific Inc. specializes in the design, manufacturing and marketing of laboratory and scientific equipments. Net sales (including intragroup) break down by family of products as follows: - laboratory equipments (70%). Moreover, the group proposes chemical products (reagents, solvent, salts, etc.), consumable products (tubes, funnels, vials, etc.), as well as conditioning, warehousing, storage, etc.; - diagnostics equipment and products (15.3%); - scientific analysis equipments (14.7%): analyzer (of water, gas, grounds, etc.), mass spectrometers, molecular spectroscopes, microscopes, manometers, samplers, microbiology equipments, reactive agents, etc. Net sales break down by source of income into products sales (78.5%) and services (21.5%). Net sales break down geographically as follows: North America (53%), Europe (25.7%), Asia-Pacific (18.1%) and others (3.2%).
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
27
Last Close Price
564.7 USD
Average target price
597.3 USD
Spread / Average Target
+5.78%
Consensus
+229% on MICROSOFT CORPORATION since our purchase on January 11, 2019
Replicate our performance
fermer